- 1.
Rosendaal FR. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1997; 78: 1 – 6.
- 2.
Lowe GDO and the Thromboembolic Risk Factors (THRIFT) Consensus Group. Regular review: risk and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992; 305: 567 – 74.
- 3.
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995; 346: 1575 – 82.
- 4.
Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593 – 6.
- 5.
Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, MacRae KD on behalf of Transnational Research Group on Oral Contraceptives and the Health of Young Women. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. BMJ 1996; 312: 83 – 8.
- 6.
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582 – 8.
- 7.
Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen componants. Lancet 1995; 346: 1589 – 93.
- 8.
Farmer RDT, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997; 349: 83 – 8.
- 9.
Grodstein F, Stampfer MJ, Goldhaber SZ, Manson JE, Colditz GA, Speitzer FE et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983 – 7.
- 10.
Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KWM, Rosendaal FR. Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation. Am J Obstet Gynecol 1997; 177: 887 – 91.
- 11.
Helmerhorst FM, Bloemenkamp KWM, Rosendaal FR, Vandenbroucke JP. Oral contraceptives and thrombotic disease: risk of venous thromboembolism. Thromb Haemost 1997; 78: 327 – 33.
- 12.
Lidegaard Ø, Milsom I. Oral contraceptive and thrombotic diseases: impact of new epidemiological studies. Contraception 1996; 53: 135 – 9.
- 13.
WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives. Description and validation of methods. J Clin Epidemiol 1995; 48: 1513 – 47.
- 14.
Stein PD. Acute pulmonary embolism. Disease-a-Month 1994; 40: 467 – 523.
- 15.
Anderson FA, Wheeler B, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B et al. Population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933 – 8.
- 16.
Silverstein MD, Heit JA, Mohr DN, Petterson TM, O"Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism. Arch Intern Med 1998; 158: 585 – 93.
- 17.
Strekerud F, Johansen AM, Abildgaard U. Venøs tromboembolisme – insidens og risikofaktorer i Oslo. Tidsskr Nor Lægeforen 1998; 118: 3934 – 7.
- 18.
Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162 – 73.
- 19.
Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992; 79: 1 – 17.
- 20.
Lidegaard Ø. P-piller og trombose. Nord Med 1998; 113: 187 – 90.
- 21.
Filipecki S, Kober J, Kaminski D, Tomkowski W. Pulmonary thromboembolism. Monaldi Arch Chest Dis 1997; 52: 492 – 3.
- 22.
Alessandri C, Basili S, Violi F, Ferroni P, Gazzangia PP, Cordova C et al. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Thromb Haemost 1994; 72: 343 – 6.
- 23.
Lesser BA, Leeper KV, Stein PD, Saltzman HA, Chen J, Thompson BT et al. The diagnosis of acute pulmonary embolism in patients with chronic obstructive pulmonary disease. Chest 1992; 102: 17 – 22.
- 24.
Skjeldestad FE. Choice of contraceptive modality by women in Norway. Acta Obstet Gynecol Scand 1993; 72: 48 – 52.
- 25.
Oddens B, Milsom I. Contraceptive practice and attitudes in Sweden 1994. Acta Obstet Gynecol Scand 1996; 75: 932 – 40.
- 26.
Osler M, Riphagen FE. Contraceptive survey: Denmark 1988. Contraception 1990; 42: 507 – 21.
- 27.
Makkonen K, Hemminki E. Different contraceptive practices: use of contraceptives in Finland and other Nordic countries in the 1970s and 1980s. Scand J Soc Med 1991; 19: 32 – 8.
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.